| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.22 | 4e-05 |